Literature DB >> 21942925

Inflammation protein SAA2.2 spontaneously forms marginally stable amyloid fibrils at physiological temperature.

Zhuqiu Ye1, Diane Bayron Poueymiroy, J Javier Aguilera, Saipraveen Srinivasan, Yun Wang, Louise C Serpell, Wilfredo Colón.   

Abstract

For nearly four decades, the formation of amyloid fibrils by the inflammation-related protein serum amyloid A (SAA) has been pathologically linked to the disease amyloid A (AA) amyloidosis. However, here we show that the nonpathogenic murine SAA2.2 spontaneously forms marginally stable amyloid fibrils at 37 °C that exhibit cross-beta structure, binding to thioflavin T, and fibrillation by a nucleation-dependent seeding mechanism. In contrast to the high stability of most known amyloid fibrils to thermal and chemical denaturation, experiments monitored by glutaraldehyde cross-linking/SDS-PAGE, thioflavin T fluorescence, and light scattering (OD(600)) showed that the mature amyloid fibrils of SAA2.2 dissociate upon incubation in >1.0 M urea or >45 °C. When considering the nonpathogenic nature of SAA2.2 and its ~1000-fold increased concentration in plasma during an inflammatory response, its extreme in vitro amyloidogenicity under physiological-like conditions suggest that SAA amyloid might play a functional role during inflammation. Of general significance, the combination of methods used here is convenient for exploring the stability of amyloid fibrils that are sensitive to urea and temperature. Furthermore, our studies imply that analogous to globular proteins, which can possess structures ranging from intrinsically disordered to extremely stable, amyloid fibrils formed in vivo might have a broader range of stabilities than previously appreciated with profound functional and pathological implications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21942925      PMCID: PMC3204343          DOI: 10.1021/bi200856v

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  56 in total

1.  The N-terminal prion domain of Ure2p converts from an unfolded to a thermally resistant conformation upon filament formation.

Authors:  Ulrich Baxa; Philip D Ross; Reed B Wickner; Alasdair C Steven
Journal:  J Mol Biol       Date:  2004-05-28       Impact factor: 5.469

Review 2.  The thermodynamic stability of proteins.

Authors:  J A Schellman
Journal:  Annu Rev Biophys Biophys Chem       Date:  1987

3.  Metastability of native proteins and the phenomenon of amyloid formation.

Authors:  Andrew J Baldwin; Tuomas P J Knowles; Gian Gaetano Tartaglia; Anthony W Fitzpatrick; Glyn L Devlin; Sarah Lucy Shammas; Christopher A Waudby; Maria F Mossuto; Sarah Meehan; Sally L Gras; John Christodoulou; Spencer J Anthony-Cahill; Paul D Barker; Michele Vendruscolo; Christopher M Dobson
Journal:  J Am Chem Soc       Date:  2011-08-19       Impact factor: 15.419

4.  Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis.

Authors:  F C De Beer; R K Mallya; E A Fagan; J G Lanham; G R Hughes; M B Pepys
Journal:  Lancet       Date:  1982-07-31       Impact factor: 79.321

5.  Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1.

Authors:  H Naiki; K Higuchi; M Hosokawa; T Takeda
Journal:  Anal Biochem       Date:  1989-03       Impact factor: 3.365

6.  Murine amyloid protein AA in casein-induced experimental amyloidosis.

Authors:  M Skinner; T Shirahama; M D Benson; A S Cohen
Journal:  Lab Invest       Date:  1977-04       Impact factor: 5.662

7.  Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo.

Authors:  A Husebekk; B Skogen; G Husby; G Marhaug
Journal:  Scand J Immunol       Date:  1985-03       Impact factor: 3.487

8.  Structural prerequisites for serum amyloid A fibril formation.

Authors:  M C de Beer; F C de Beer; W D McCubbin; C M Kay; M S Kindy
Journal:  J Biol Chem       Date:  1993-09-25       Impact factor: 5.157

9.  Murine tissue amyloid protein AA. NH2-terminal sequence identity with only one of two serum amyloid protein (ApoSAA) gene products.

Authors:  J S Hoffman; L H Ericsson; N Eriksen; K A Walsh; E P Benditt
Journal:  J Exp Med       Date:  1984-02-01       Impact factor: 14.307

10.  Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein.

Authors:  K P McAdam; J D Sipe
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

View more
  4 in total

1.  Uncovering the universality of self-replication in protein aggregation and its link to disease.

Authors:  Georg Meisl; Catherine K Xu; Jonathan D Taylor; Thomas C T Michaels; Aviad Levin; Daniel Otzen; David Klenerman; Steve Matthews; Sara Linse; Maria Andreasen; Tuomas P J Knowles
Journal:  Sci Adv       Date:  2022-08-12       Impact factor: 14.957

2.  Pathogenic serum amyloid A 1.1 shows a long oligomer-rich fibrillation lag phase contrary to the highly amyloidogenic non-pathogenic SAA2.2.

Authors:  Saipraveen Srinivasan; Sanket Patke; Yun Wang; Zhuqiu Ye; Jeffrey Litt; Sunit K Srivastava; Maria M Lopez; Dmitry Kurouski; Igor K Lednev; Ravi S Kane; Wilfredo Colón
Journal:  J Biol Chem       Date:  2012-12-05       Impact factor: 5.157

3.  Cryo-EM demonstrates the in vitro proliferation of an ex vivo amyloid fibril morphology by seeding.

Authors:  Thomas Heerde; Matthies Rennegarbe; Alexander Biedermann; Dilan Savran; Peter B Pfeiffer; Manuel Hitzenberger; Julian Baur; Ioana Puscalau-Girtu; Martin Zacharias; Nadine Schwierz; Christian Haupt; Matthias Schmidt; Marcus Fändrich
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 14.919

4.  Characterization of the oligomerization and aggregation of human Serum Amyloid A.

Authors:  Sanket Patke; Saipraveen Srinivasan; Ronak Maheshwari; Sunit K Srivastava; J Javier Aguilera; Wilfredo Colón; Ravi S Kane
Journal:  PLoS One       Date:  2013-06-04       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.